Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology.

IF 3.4 3区 医学 Q1 PATHOLOGY Virchows Archiv Pub Date : 2024-11-01 Epub Date: 2024-10-02 DOI:10.1007/s00428-024-03933-2
Marius Ilié, Vivien Lake, Enrique de Alava, Serena Bonin, Sandra Chlebowski, Aurélie Delort, Elisabeth Dequeker, Raed Al-Dieri, Arjan Diepstra, Olli Carpén, Catarina Eloy, Ambrogio Fassina, Falko Fend, Pedro L Fernandez, Gregor Gorkiewicz, Simon Heeke, Rui Henrique, Gerald Hoefler, Pablo Huertas, Michael Hummel, Karl Kashofer, Jeroen van der Laak, Rocio Martinez de Pablos, Fernando Schmitt, Ed Schuuring, Giorgio Stanta, Wim Timens, Benedikt Westphalen, Paul Hofman
{"title":"Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology.","authors":"Marius Ilié, Vivien Lake, Enrique de Alava, Serena Bonin, Sandra Chlebowski, Aurélie Delort, Elisabeth Dequeker, Raed Al-Dieri, Arjan Diepstra, Olli Carpén, Catarina Eloy, Ambrogio Fassina, Falko Fend, Pedro L Fernandez, Gregor Gorkiewicz, Simon Heeke, Rui Henrique, Gerald Hoefler, Pablo Huertas, Michael Hummel, Karl Kashofer, Jeroen van der Laak, Rocio Martinez de Pablos, Fernando Schmitt, Ed Schuuring, Giorgio Stanta, Wim Timens, Benedikt Westphalen, Paul Hofman","doi":"10.1007/s00428-024-03933-2","DOIUrl":null,"url":null,"abstract":"<p><p>Despite advancements in precision medicine, many cancer patients globally, particularly those in resource-constrained environments, face significant challenges in accessing high-quality molecular testing and targeted therapies. The considerable heterogeneity in molecular testing highlights the urgent need to harmonize practices across Europe and beyond, establishing a more standardized and consistent approach in MP laboratories. Professionals, especially molecular pathologists, must move beyond traditional education to cope with this heterogeneity. This perspective addresses critical issues in molecular pathology (MP), such as limited access to high-quality molecular testing, leading to disparities in cancer treatment, and the consequences of inconsistent practices. Recognizing the necessity for a standardized framework for education to address these issues, educational programs play a pivotal role in updating professionals' skills to achieve standardization in MP. European experts from the Steering Committee, the Pathology Section of the European Union of Medical Specialists, and the European Society of Pathology have proposed creating a comprehensive Master's degree program called the \"European Masters in Molecular Pathology\" (EMMP). This program emerges as a strategic response to the demand for a specialized and standardized framework for education in MP, catering to professionals who concurrently work and study. The program's design aligns with evidence-based education methods, ensuring effective learning and engagement while integrating computational pathology to analyze complex molecular data, enhance diagnostic accuracy, and improve treatment outcomes. EMMP's structured curriculum, strategic partnerships, and regular updates underscore its significance in standardizing MP practices. Exploring future developments, this perspective delves into technology integration and interdisciplinary collaboration, anticipating ongoing advances and harmonization. Challenges and future directions in MP education are discussed, emphasizing the necessity for dynamic curriculum updates, seamless technology integration, and interdisciplinary cooperation. This perspective underscores EMMP's pivotal role in preparing pathologists for this dynamic field, advocating continuous advancements in education and training to uphold excellence in MP practices and maintain the highest patient care standards.</p>","PeriodicalId":23514,"journal":{"name":"Virchows Archiv","volume":" ","pages":"761-775"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virchows Archiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00428-024-03933-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Despite advancements in precision medicine, many cancer patients globally, particularly those in resource-constrained environments, face significant challenges in accessing high-quality molecular testing and targeted therapies. The considerable heterogeneity in molecular testing highlights the urgent need to harmonize practices across Europe and beyond, establishing a more standardized and consistent approach in MP laboratories. Professionals, especially molecular pathologists, must move beyond traditional education to cope with this heterogeneity. This perspective addresses critical issues in molecular pathology (MP), such as limited access to high-quality molecular testing, leading to disparities in cancer treatment, and the consequences of inconsistent practices. Recognizing the necessity for a standardized framework for education to address these issues, educational programs play a pivotal role in updating professionals' skills to achieve standardization in MP. European experts from the Steering Committee, the Pathology Section of the European Union of Medical Specialists, and the European Society of Pathology have proposed creating a comprehensive Master's degree program called the "European Masters in Molecular Pathology" (EMMP). This program emerges as a strategic response to the demand for a specialized and standardized framework for education in MP, catering to professionals who concurrently work and study. The program's design aligns with evidence-based education methods, ensuring effective learning and engagement while integrating computational pathology to analyze complex molecular data, enhance diagnostic accuracy, and improve treatment outcomes. EMMP's structured curriculum, strategic partnerships, and regular updates underscore its significance in standardizing MP practices. Exploring future developments, this perspective delves into technology integration and interdisciplinary collaboration, anticipating ongoing advances and harmonization. Challenges and future directions in MP education are discussed, emphasizing the necessity for dynamic curriculum updates, seamless technology integration, and interdisciplinary cooperation. This perspective underscores EMMP's pivotal role in preparing pathologists for this dynamic field, advocating continuous advancements in education and training to uphold excellence in MP practices and maintain the highest patient care standards.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过分子病理学教育实现标准化:聚焦欧洲分子病理学硕士课程。
尽管精准医疗取得了进步,但全球许多癌症患者,尤其是那些资源有限的患者,在获得高质量分子检测和靶向治疗方面仍面临巨大挑战。分子检测中存在的巨大差异凸显出迫切需要协调欧洲及其他地区的做法,在重大疾病实验室中建立更加标准化和一致的方法。专业人员,尤其是分子病理学家,必须超越传统教育,以应对这种异质性。本视角探讨了分子病理学(MP)中的关键问题,如获得高质量分子检测的机会有限,导致癌症治疗中的差异,以及不一致做法的后果。由于认识到有必要建立一个标准化的教育框架来解决这些问题,因此教育计划在更新专业人员技能以实现分子病理学标准化方面发挥了关键作用。来自指导委员会、欧洲医学专家联盟病理学分会和欧洲病理学会的欧洲专家建议设立一个名为 "欧洲分子病理学硕士"(EMMP)的综合硕士学位课程。该项目是对专业化和标准化的分子病理学教育框架需求的战略回应,旨在满足同时工作和学习的专业人士的需求。该计划的设计符合循证教育方法,确保有效的学习和参与,同时结合计算病理学来分析复杂的分子数据,提高诊断准确性,改善治疗效果。EMMP 的结构化课程、战略合作伙伴关系和定期更新强调了其在标准化 MP 实践中的重要意义。在探索未来发展的过程中,本视角深入研究了技术整合和跨学科合作,预计将不断取得进步并实现协调统一。讨论了重大计划教育的挑战和未来方向,强调了动态课程更新、无缝技术整合和跨学科合作的必要性。这一观点强调了 EMMP 在培养病理学家进入这一充满活力的领域方面所起的关键作用,倡导不断推进教育和培训,以维护卓越的病理实践,保持最高的患者护理标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Virchows Archiv
Virchows Archiv 医学-病理学
CiteScore
7.40
自引率
2.90%
发文量
204
审稿时长
4-8 weeks
期刊介绍: Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.
期刊最新文献
Heterogeneity of pancreatic neoplasms arising in pancreatic heterotopia: a single institution review. Massive parallel sequencing of head and neck conventional squamous cell carcinomas: A comprehensive review. A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor. Expanding horizons in a new era for pathology: perspectives from the ASCO meeting. Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1